- Home
- WIMI vs TENX Comparison
WIMI vs TENX Comparison
Compare WIMI & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIMI
- TENX
- Stock Information
- Founded
- WIMI 2015
- TENX 1967
- Country
- WIMI China
- TENX United States
- Employees
- WIMI 107
- TENX N/A
- Industry
- WIMI Computer Software: Prepackaged Software
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- WIMI Technology
- TENX Health Care
- Exchange
- WIMI Nasdaq
- TENX Nasdaq
- Market Cap
- WIMI 23.9M
- TENX 21.6M
- IPO Year
- WIMI 2020
- TENX N/A
- Fundamental
- Price
- WIMI $3.18
- TENX $5.90
- Analyst Decision
- WIMI
- TENX Strong Buy
- Analyst Count
- WIMI 0
- TENX 3
- Target Price
- WIMI N/A
- TENX $16.00
- AVG Volume (30 Days)
- WIMI 7.6M
- TENX 41.0K
- Earning Date
- WIMI 01-01-0001
- TENX 08-12-2025
- Dividend Yield
- WIMI N/A
- TENX N/A
- EPS Growth
- WIMI N/A
- TENX N/A
- EPS
- WIMI N/A
- TENX N/A
- Revenue
- WIMI $84,137,968.00
- TENX N/A
- Revenue This Year
- WIMI N/A
- TENX N/A
- Revenue Next Year
- WIMI N/A
- TENX N/A
- P/E Ratio
- WIMI N/A
- TENX N/A
- Revenue Growth
- WIMI 19.25
- TENX N/A
- 52 Week Low
- WIMI $0.27
- TENX $2.80
- 52 Week High
- WIMI $2.92
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- WIMI 60.88
- TENX 53.33
- Support Level
- WIMI $2.73
- TENX $5.68
- Resistance Level
- WIMI $3.09
- TENX $5.96
- Average True Range (ATR)
- WIMI 0.26
- TENX 0.32
- MACD
- WIMI 0.15
- TENX 0.01
- Stochastic Oscillator
- WIMI 83.58
- TENX 27.47
About WIMI WiMi Hologram Cloud Inc.
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.